0
0
8/28/22 at 12:18pm
Organization
Canada NewsWire
39 words
0
Comments
/CNW/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that its investigational EV ICD™ System – a first-of-its-kind...
You are the first to view
https://www.newswire.ca/news-releases/medtronic-extravascular-icd-meets-global-pivotal-clinical-trial-s-safety-and-effectiveness-endpoints-840548088.html
Create an account
or login to join the discussion